Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving the drug during early gestation. Researchers at Baylor College of ...
from Google Alert - health https://ift.tt/2LEIkKs
via IFTTT
0 comments:
Post a Comment